|
시장보고서
상품코드
2128967
말단비대증 치료 시장 : 제품 유형별, 투여 경로별, 유통 채널별, 치료법별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Acromegaly Treatment Market, By Product Type, By Route of Administration, By Distribution Channel, By Treatment Type, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
2025년 말단비대증 치료 시장 규모는 18억 760만 달러로 평가되었고, 2026-2033년 CAGR 6.5%로 성장할 전망입니다.
말단비대증 치료 시장은 수술이 적합하지 않거나, 수술이 실패했거나, 또는 효과를 얻지 못한 경우 생화학적 조절을 지원하는 광범위한 약물 요법 및 치료 모니터링으로 구성되어 있습니다. 이 치료에 사용되는 주요 제품으로는 소마토스타틴 유사체, 성장 호르몬 수용체 길항제, 도파민 작용제, 그리고 새로운 내분비 요법이 있습니다. 현재 치료 선택은 IGF-1 기반 반응률, 종양의 특성, 내약성, 치료의 복잡성, 투여 부담 및 과거 치료 경험과 같은 매개변수에 따라 더욱 명확하게 결정되고 있습니다. 2025년에도 치료법 선택지는 약물 유형별로 여전히 폭넓지만, 미국에서 팔츠소틴의 사용이 FDA에 의해 승인됨에 따라 경구 투여 시장의 중요성은 높아지고 있습니다. 소마토스타틴 유사체, 도파민 작용제, 페그비소만트는 FDA가 치료법으로 승인한 것 중 일부입니다. 따라서 시장 점유율은 더 이상 제공되는 치료법의 수에 의해 결정되는 것이 아니라, 효능, 편의성, 그리고 개인 맞춤화에 의해 결정되고 있습니다.
말단비대증 치료 시장 : 시장 역학
경구 투여가 치료의 편의성과 제품 간 경쟁 구도를 재편하고 있습니다.
단기적인 강력한 촉진요인으로는 경구 제제를 통한 부담이 적은 치료 추세가 꼽힙니다. 2025년 9월, FDA는 성인 환자의 말단비대증 치료를 위한 최초의 1일 1회 경구 투여 요법인 파르토소틴을 승인했습니다. 이 FDA 승인은 18개국 73개 기관에서 169명의 환자를 대상으로 한 2건의 제3상 주요 임상시험을 기반으로 하며, 해당 약물의 유효성이 입증되었습니다. 24주 시점의 생화학적 조절률은 한 임상시험에서는 치료군의 56%, 다른 임상시험에서는 83%에서 달성된 반면, 위약군에서는 각각 5%와 4%에 그쳤습니다. 그 결과, 1일 1회 투여라는 편의성을 갖춘 이 약물의 상업적 성공은 큰 탄력을 얻었으며, 시중에 나와 있는 다른 주사제들에게는 과제가 되었습니다. 이러한 상황에서 투여의 용이성은 중요하고 지속적으로 진화하는 경쟁 요인이 되고 있습니다.
말단비대증 치료 시장 : 시장 세분화 분석
세계 말단비대증 치료 시장은 제품 유형, 투여 경로, 유통 채널, 치료 유형 및 지역을 기준으로 세분화되어 있습니다.
제품 유형별로는 성장 호르몬 수용체 길항제가 주로 다른 약물로 생화학적 조절이 불가능한 증례에 적용되고 있으며, 페그비소만트는 성장 호르몬 수용체를 억제하여 IGF-1 수치를 낮춥니다. 소마토스타틴 수용체 작용제는 성장 호르몬 분비를 억제하는 능력이 있어 약물 요법의 주요 범주를 형성하고 있지만, 도파민 작용제의 사용은 많은 환자에서 효과가 낮기 때문에 일반적으로 더 제한된 대상에게 사용됩니다. 소마토스타틴 수용체 작용제 경구제인 팔츠소틴(상품명 : 팔소니파이)은 FDA 승인을 거쳐 2025년에 시장에 출시되었습니다. 이번 승인으로 인해 수술에 반응하지 않거나 수술이 선택지가 되지 않는 성인 거대증 환자에게 1일 1회 경구 투여가 가능한 약제가 제공되게 되었습니다.
투여 경로별로 보면, 말단비대증 진단에서 임상 검사가 주요 부분을 차지하며, 선별 검사를 목적으로 IGF-1 수치를 평가하고, 성장 호르몬 억제 검사를 통해 진단이 확정됩니다. 마찬가지로 영상 진단도 평가의 중요한 요소이며, 일반적으로 MRI를 이용하여 뇌하수체를 시각화하고 종양의 크기와 위치를 파악합니다. 임상 검사와 영상 진단은 서로 보완적으로 활용되며, 전자는 호르몬 농도를 평가하여 진단을 확정하고, 후자는 종양의 특성을 파악합니다. 2025년, 파르토소틴의 FDA 임상시험에서는 치료에 대한 생화학적 반응의 주요 지표로 IGF-1 농도가 사용되었습니다. 따라서 임상 검사는 말단비대증 평가의 기반이 되며, 임상의가 약물 요법을 선택할 때 지침이 됩니다.
말단비대증 치료 시장 : 지역별 분석
북미는 확립된 내분비 치료제의 존재, 규제 당국의 활동, 전문적인 의료 체계, 그리고 혁신적인 치료법의 상용화를 통해 계속해서 주요 시장으로서의 지위를 유지하고 있습니다. 특히 2025년 9월, 18개국 73개 기관의 환자 169명을 대상으로 한 2건의 제3상 주요 임상시험이 완료된 후, FDA는 파르토소틴을 승인했습니다. 이를 통해 말단비대증에 대한 FDA 최초의 1일 1회 경구 투여 요법이 탄생했습니다. Crinetics사에 따르면, 자사의 영업팀은 제품 출시 기간 동안 주요 보험사 및 대상 의사의 95% 이상과 접촉했습니다. 이러한 전문의 중심의 접근 방식을 통해 회사는 시장에서 확고한 입지를 다질 수 있었습니다. 따라서 북미는 혁신적이고 편의성이 높은 치료법에 있어 중요한 거점이 되고 있습니다.
유럽은 확립된 치료 센터와 전문의 네트워크가 존재하며, 정평이 나 있는 장기 작용형 소마토스타틴 유사체를 이용할 수 있다는 점에서 중요한 시장으로 자리매김하고 있습니다. 입센(Ipsen)에 따르면, 2025년 말 기준으로 ‘소마토린 오토젤/데포’는 전 세계 약 70개국에서 판매되고 있었습니다. 또한 이 회사는 2025년 소마트린 매출의 52.1%가 북미에서 발생했다고 보고했으며, 이를 통해 유럽은 독립된 지역 시장이라기보다는 세계 공급·판매 네트워크의 일부로서의 역할이 부각되었습니다. 이처럼 유럽 시장은 주로 치료 전문의 확보 현황, 기존 주사 요법의 이용 현황, 그리고 편의성이 더 높은 치료법으로의 전환과 같은 요인의 영향을 받고 있습니다.
목차
제1장 말단비대증 치료 시장 개요
제2장 주요 요약
제3장 말단비대증 치료 주요 시장 동향
제4장 말단비대증 치료 산업 분석
제5장 말단비대증 치료 시장 : 높아지는 지정학적 긴장의 영향
제6장 말단비대증 치료 시장 구도
제7장 말단비대증 치료 시장 : 제품 유형별
제8장 말단비대증 치료 시장 : 투여 경로별
제9장 말단비대증 치료 시장 : 유통 채널별
제10장 말단비대증 치료 시장 : 치료 유형별
제11장 말단비대증 치료 시장 : 지역별
제12장 주요 벤더 분석 : 말단비대증 치료 산업
제13장 AnalystView 전방위 전망
AJY 26.09.17Acromegaly Treatment Market size was valued at US$ 1,807.6 Million in 2025, expanding at a CAGR of 6.5% from 2026 to 2033.
The acromegaly treatment market comprises a wide range of drug therapies and therapy monitoring that aids biochemical control when surgery may not be appropriate, unsuccessful, or ineffective. The key products used in its treatment are somatostatin analogs, growth hormone receptor antagonists, dopamine agonists, and newer endocrine therapies. The choice of treatment is now more firmly directed by parameters such as the rate of response in terms of IGF-1, tumor characteristics, tolerability, complexity, burden of dosing, and past treatment experience. In 2025, therapeutic choices remain broad class-wise, while oral delivery has increased market significance after the FDA approval of paltusotine for use in the USA. Somatostatin analogs, dopamine agonists, and pegvisomant are a few of those recorded by the FDA as therapies. Therefore, market share is no longer about offering treatments but about effectiveness, convenience, and individuality.
Acromegaly Treatment Market- Market Dynamics
Oral Administration Is Reshaping Treatment Convenience and Product Competition
A strong near-term driver is the trend toward less burdensome administration via an oral formulation. In September 2025, the FDA approved paltusotine, the first once-daily oral therapy for the treatment of acromegaly in adult patients. The FDA approval was based on two pivotal phase III trials, which enrolled 169 patients across 73 centers in 18 countries, demonstrating the drug's efficacy: biochemical control at week 24 was achieved in 56% of treated patients in one trial and 83% in another, compared to 5% and 4% with placebo, respectively. As a result, the commercial success of convenient once-daily dosing gained significant momentum, creating a challenge for other injectable agents on the market. In this context ease of administration is a relevant and evolving competitive factor.
Acromegaly Treatment Market- Segmentation Analysis:
The Global Acromegaly Treatment Market is segmented on the basis of Product Type, Route of Administration, Distribution Channel, Treatment Type, and Region.
By product type, the growth hormone receptor antagonists are mainly indicated in cases where biochemical control is not achieved by using other forms of medication, with pegvisomant causing a decrease in IGF-1 by inhibiting the growth hormone receptor. Somatostatin receptor agonists form the main category of pharmacotherapy due to their ability to inhibit growth hormone secretion, while the use of dopamine agonists is usually more targeted, given that they are less effective in many individuals. Paltusotine, an oral form of the somatostatin receptor agonist branded Palsonify, came onto the market in 2025 after being approved by the FDA. This approval provided a once-daily oral form of medication for adults with acromegaly who do not respond to surgery or for whom surgery is not an option.
By Route of Administration, medical laboratory testing is the primary segment for diagnosing acromegaly, where IGF-1 levels are assessed for screening purposes, while growth hormone suppression tests confirm the diagnosis. Similarly, medical imaging is a critical component of evaluation, where MRI is typically used to visualize the pituitary gland and determine the tumor's size and location. Both laboratory tests and imaging are used complementarily, with the former evaluating hormone levels and establishing the diagnosis, while the latter determines the tumor's characteristics. In 2025, FDA trials for paltusotine used IGF-1 levels as the main indicator of biochemical response to treatment. Therefore, medical testing is the cornerstone of evaluating acromegaly, which guides clinicians in the selection of pharmacological interventions.
Acromegaly Treatment Market- Geographical Insights
North America remains leading market due to the presence of well-established endocrine therapeutics, regulatory activity, specialized care, and commercialization of innovative modes of therapy. In particular, in September 2025, the FDA approved paltusotine after two pivotal phase III trials were completed across 73 centers and 169 patients in 18 countries. This led to the first FDA-approved once-daily oral therapy for acromegaly. According to Crinetics, the company's sales force contacted more than 95% of key payers and target physicians during the product launch period. This specialty-centric approach helped the company achieve a significant foothold in the market. North America is, therefore, an important base for innovative and convenient modes of therapy.
Europe is an important market due to the presence of well-established treatment centers, a network of specialist physicians, and access to established long-acting somatostatin analogs. According to Ipsen, Somatuline Autogel/Depot was available in nearly 70 different countries worldwide at the end of 2025. The company also reported that 52.1% of the 2025 Somatuline sales were made in North America, thus highlighting the role of Europe as part of a global supply and sales network, rather than a stand-alone regional market. As such, the European market is mainly influenced by the availability of treatment specialties, the use of existing injectable therapies, and the shift towards more convenient approaches.
Acromegaly Treatment Market- Competitive Landscape:
Market competition in the treatment of acromegaly now revolves around mechanisms of action, biochemical control, administration frequency, tolerability, and administration convenience. Long-acting somatostatin receptor agonists will continue to play an important role due to the mechanism involved in biochemical disease control, whereas pegvisomant represents an alternative method of disease management through a growth hormone receptor antagonist. Oral medication administration has gained increasing importance with the FDA approval of Palsonify (paltusotine) in September 2025, an orally administered somatostatin receptor agonist taken on a daily basis. The new option introduces greater administration convenience compared with injectable therapies and may intensify competition regarding adherence, patient preference, treatment switching, and long-term disease management.
Recent Developments:
In September 2025, Crinetics Pharmaceuticals received FDA approval for Palsonify (paltusotine) for the treatment of acromegaly in adults who are unsuitable for surgery or have had an inadequate response to surgery. The new therapy was the first once-daily oral treatment for acromegaly in the United States, differentiating itself through the convenience of administration.
In November 2025, Crinetics announced that Palsonify had been launched in the U.S., with the company's field force having engaged with over 95% of key care providers. Early market feedback suggested that the product was being adopted by both switchers and new users, providing commercial validation for the oral formulation
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ACROMEGALY TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Novartis AG
- Ipsen Biopharmaceuticals, Inc.
- Pfizer Inc.
- Recordati S.p.A.
- Chiesi Farmaceutici S.p.A.
- Crinetics Pharmaceuticals, Inc.
- Camurus AB
- Ionis Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- Merck & Co., Inc.
- Wockhardt Ltd.
- Dauntless Pharmaceuticals
- GlaxoSmithKline plc
- Cipla Ltd.
- Others
GLOBALACROMEGALY TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Growth Hormone Receptor Antagonists
- Somatostatin Analogs
- Dopamine Agonists
- Others
GLOBAL ACROMEGALY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033
- Injectable
- Oral
GLOBAL ACROMEGALY TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020 - 2033
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
GLOBAL ACROMEGALY TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2020 - 2033
- Drug Therapy
- Surgery
- Radiation Therapy
GLOBAL ACROMEGALY TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Acromegaly Treatment Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Acromegaly Treatment Market Snippet by Product Type
- 2.1.2. Acromegaly Treatment Market Snippet by Route of Administration
- 2.1.3. Acromegaly Treatment Market Snippet by Distribution Channel
- 2.1.4. Acromegaly Treatment Market Snippet by Treatment Type
- 2.1.5. Acromegaly Treatment Market Snippet by Country
- 2.1.6. Acromegaly Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Acromegaly Treatment Key Market Trends
- 3.1. Acromegaly Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Acromegaly Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Acromegaly Treatment Market Opportunities
- 3.4. Acromegaly Treatment Market Future Trends
4. Acromegaly Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Acromegaly Treatment Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Acromegaly Treatment Market Landscape
- 6.1. Acromegaly Treatment Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Acromegaly Treatment Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Growth Hormone Receptor Antagonists
- 7.1.3. Somatostatin Analogs
- 7.1.4. Dopamine Agonists
- 7.1.5. Others
8. Acromegaly Treatment Market - By Route of Administration
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
- 8.1.2. Injectable
- 8.1.3. Oral
9. Acromegaly Treatment Market - By Distribution Channel
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
- 9.1.2. Retail Pharmacies
- 9.1.3. Hospital Pharmacies
- 9.1.4. Online Pharmacies
10. Acromegaly Treatment Market - By Treatment Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Treatment Type, 2025 & 2033 (%)
- 10.1.2. Drug Therapy
- 10.1.3. Surgery
- 10.1.4. Radiation Therapy
11. Acromegaly Treatment Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Acromegaly Treatment Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Acromegaly Treatment Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.17.4. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.17.5. Denmark Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.17.6. Denmark Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
- 11.3.18.1. Overview
- 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.3.18.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.3.18.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.3.18.6. Rest of the Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Acromegaly Treatment Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.16.4. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.16.5. Taiwan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.16.6. Taiwan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
- 11.4.17.1. Overview
- 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.17.4. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.17.5. Vietnam Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.17.6. Vietnam Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
- 11.4.18.1. Overview
- 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.4.18.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.4.18.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.4.18.6. Rest of APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Acromegaly Treatment Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Acromegaly Treatment Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.14.4. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.14.5. Iran Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.14.6. Iran Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
- 11.6.15.1. Overview
- 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.15.4. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.15.5. Qatar Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.15.6. Qatar Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
- 11.6.16.1. Overview
- 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 11.6.16.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
- 11.6.16.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
- 11.6.16.6. Rest of MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Acromegaly Treatment Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Novartis AG
- 12.2.2. Ipsen Biopharmaceuticals, Inc.
- 12.2.3. Pfizer Inc.
- 12.2.4. Recordati S.p.A.
- 12.2.5. Chiesi Farmaceutici S.p.A.
- 12.2.6. Crinetics Pharmaceuticals, Inc.
- 12.2.7. Camurus AB
- 12.2.8. Ionis Pharmaceuticals, Inc.
- 12.2.9. Sun Pharmaceutical Industries Ltd.
- 12.2.10. F. Hoffmann-La Roche Ltd.
- 12.2.11. Merck & Co., Inc.
- 12.2.12. Wockhardt Ltd.
- 12.2.13. Dauntless Pharmaceuticals
- 12.2.14. GlaxoSmithKline plc
- 12.2.15. Cipla Ltd.
- 12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
